Listen "AMD/Retina Edition: Top Headlines for Week of August 29, 2022"
Episode Synopsis
In this edition, macular retinal nerve fiber layer thickness linked with cognitive decline; FDA approves Lucentis biosimilar; advanced visual field loss risk higher after glaucoma diagnosis in Black patients; and more. Association found between macular retinal nerve fiber layer thickness, cognitive decline FDA approves Cimerli as interchangeable biosimilar to Lucentis Black patients have higher risk for advanced visual field loss after glaucoma diagnosis iStent infinite cleared by FDA Alcon to acquire Aerie Pharmaceuticals References: Kang JH, et al. Transl Vis Sci Technol. 2022;doi:10.1167/tvst.11.7.21. Kim HM, et al. JAMA Ophthalmol. 2022;doi:10.1001/jamaophthalmol.2022.1563. Press Release Press Release Press Release
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.